Fed Circ denies Sun Pharma patent for alopecia treatment

Indian drugmaker had challenged PTAB decision that patent for new version of ruxolitinib was invalid as obvious | Decision hands a victory to US rival.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Court denies Sun Pharma’s bid to avoid trial

25 November 2021 Sun Pharma’s bid to avoid facing a trial over allegations of antitrust behaviour by an Indian drugmaker it acquired has been denied by a Massachusetts court.

Americas

Orexo sues Sun Pharma over opioid dependence generic

16 September 2020 Swedish pharmaceutical company Orexo has taken India-based Sun Pharmaceutical to court in the US, over its plans to launch a generic version of Orexo’s opioid dependence treatment.

More on this story

Big Pharma

Court denies Sun Pharma’s bid to avoid trial

25 November 2021 Sun Pharma’s bid to avoid facing a trial over allegations of antitrust behaviour by an Indian drugmaker it acquired has been denied by a Massachusetts court.

Americas

Orexo sues Sun Pharma over opioid dependence generic

More on this story

Big Pharma

Court denies Sun Pharma’s bid to avoid trial

25 November 2021 Sun Pharma’s bid to avoid facing a trial over allegations of antitrust behaviour by an Indian drugmaker it acquired has been denied by a Massachusetts court.

Americas

Orexo sues Sun Pharma over opioid dependence generic